UBS Group’s Sonoma Pharmaceuticals, Inc. Warrants SNOAW Stock Holding History

UBS Group’s Portfolio SNOAW Stock Details SNOAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-466	Closed	–	–	8486
2019 Q2	$0	Sell	466 -3,700	-89%	-$40	﹤0.01%	8396
2019 Q1	$0	Hold	4,166	–	–	﹤0.01%	8467
2018 Q4	$0	Buy	+4,166	New	+$107	﹤0.01%	8513
2018 Q3	–	Sell	-7,000	Closed	-$1K	–	8458
2018 Q2	$1K	Buy	7,000 +6,872	+5,369%	+$1.94K	﹤0.01%	7884
2018 Q1	$0	Sell	128 -3,579	-97%	-$1.51K	﹤0.01%	8384
2017 Q4	$2K	Buy	3,707 +255	+7%	+$97	﹤0.01%	7657
2017 Q3	$1K	Sell	3,452 -3,986	-54%	-$1.67K	﹤0.01%	7629
2017 Q2	$3K	Buy	7,438 +5,601	+305%	+$2.39K	﹤0.01%	7329
2017 Q1	$1K	Buy	+1,837	New	+$927	﹤0.01%	7511

Other funds holding SNOAW

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group's SNOAW Position: Q3 2019 in Review

UBS Group sold out of Sonoma Pharmaceuticals, Inc. Warrants (SNOAW) in Q3 2019, closing a stake of 466 shares.

UBS Group first reported a position in SNOAW in Q1 2017 and held it in 9 quarters. The position peaked at $3K in Q2 2017. 1 fund tracked by Wall St. Rank holds SNOAW as of Q3 2019.

UBS Group reported no remaining Sonoma Pharmaceuticals, Inc. Warrants position as of Q3 2019 after selling out during the quarter.
UBS Group sold 466 Sonoma Pharmaceuticals, Inc. Warrants shares in Q3 2019.
UBS Group first reported a position in Sonoma Pharmaceuticals, Inc. Warrants in Q1 2017 and held it in 9 quarters.
UBS Group's Sonoma Pharmaceuticals, Inc. Warrants position peaked at $3K in Q2 2017.
1 fund tracked by Wall St. Rank held Sonoma Pharmaceuticals, Inc. Warrants as of Q3 2019.

Based on UBS Group's 13F filing for Q3 2019, filed 14 Nov 2019.